Pyrogenesis Canada Inc. PYRGF
Annual
Quarterly
No annual revenue total was found in PYROGENESIS CANADA INC.'s SEC filings.
Pyrogenesis Canada Inc. (PYRGF) files with the SEC under industry code 2834, Pharmaceutical Preparations.
Revenue
—
Net income
—
Operating cash flow
—
Free cash flow
—
EPS
—
Dividend per share
None
Shares outstanding
173.58M
Net cash
—
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PYRGF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Quebec, Canada
- Headquarters
- Montreal, Quebec, Canada
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1743344
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
FY 2020 Dec 31, 2020 |
|---|---|---|---|
| Cash and investments | — | $12.2M | — |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 14, 2023 | Sep 30, 2023 |
| 6-K | Current report (foreign issuer) | Nov 9, 2023 | Nov 9, 2023 |
| 6-K | Current report (foreign issuer) | Nov 8, 2023 | Nov 7, 2023 |
| 6-K | Current report (foreign issuer) | Oct 30, 2023 | Oct 27, 2023 |
| 6-K | Current report (foreign issuer) | Oct 25, 2023 | Oct 24, 2023 |
| 6-K | Current report (foreign issuer) | Oct 11, 2023 | Oct 11, 2023 |
All 163 Pyrogenesis Canada Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.